We are live on
!
Find out more
FLACW
Frazier Lifesciences Acquisition Corporation Warrant
FLACW
FLACW
Delisted
FLACW was delisted on the 22nd of November, 2022.
30 hedge funds and large institutions have $1.83M invested in Frazier Lifesciences Acquisition Corporation Warrant in 2022 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
3% more funds holding
Funds holding: 29 → 30 (+1)
23% less capital invested
Capital invested by funds: $2.38M → $1.83M (-$557K)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
Holders
30
Holders Change
+1
Holders Change %
+3.45%
% of All Funds
0.47%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
3
Reduced
6
Closed
1
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$31K
Top Buyers
| 1 |
Goldman Sachs
New York
|
+$72.4K |
| 2 |
CCM
Context Capital Management
Lajolla,
California
|
+$16.3K |
| 3 |
EAM
Exos Asset Management
New York
|
+$1.54K |
| 4 |
BCM
Bluefin Capital Management
New York
|
+$96 |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$14 |
Top Sellers
| 1 |
PMAM
Picton Mahoney Asset Management
Toronto,
Ontario, Canada
|
-$21K |
| 2 |
CAC
Cowen and Company
New York
|
-$19.5K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$3.99K |
| 4 |
GCL
Glazer Capital LLC
New York
|
-$3.4K |
| 5 |
DCM
DG Capital Management
New York
|
-$2.91K |
